Tech Company Financing Transactions
Instylla Funding Round
Delos Capital, AMED Ventures and Ascension Ventures invested in a $30 million venture round for Instylla. The financing was recorded on 8/16/2023.
Transaction Overview
Company Name
Announced On
8/16/2023
Transaction Type
Venture Equity
Amount
$30,000,000
Round
Undisclosed
Investors
Proceeds Purpose
The company intends to use the funds for the ongoing prospective clinical trials and early commercialization.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
201 Burlington Rd.
Bedford, MA 01730
USA
Bedford, MA 01730
USA
Phone
Website
Email Address
Not Recorded
Overview
Instylla's focus is to leverage hydrogel technology to create differentiated liquid embolics for interventional radiology with a specific initial focus on interventional oncology and peripheral hemostasis.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Amarpreet Sawhney
President
Pat Campbell
VP - R & D
Raymond Lareau
VP - Regulatory Affairs
Brooke Mastrorio
VP - Regulatory Affairs
Amita Shah
Browse more venture capital transactions:
Prev: 8/16/2023: Rondo Energy venture capital transaction
Next: 8/16/2023: Mitra Chem venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs